Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Prime Movers Lab

Data updated

Jackson / Teton Village, Wyoming, United States

Prime Movers Lab is a venture capital firm and family of funds focused on breakthrough scientific startups, with an emphasis on technically ambitious companies in areas like energy, transportation, infrastructure, manufacturing, human augmentation, and agriculture. Public filings and firm materials place its business in Jackson/Teton Village, Wyoming, in the United States.

In the psychedelic ecosystem, Prime Movers Lab is relevant because it has explicitly backed psychedelic medicine and related neuroplasticity work, including Gilgamesh and a participation in Beckley Psytech’s most recent round through an SPV. Its public portfolio and ideas pages also show ongoing attention to psychedelics alongside adjacent neuroscience and biotech themes.

Investor Context

Venture Capital

Investment Context

This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.

Public Portfolio Examples

Prime Movers Lab presents itself as a small-number, high-conviction investor in breakthrough science, with a bias toward technically differentiated companies that can scale into large markets. Its public materials show clear interest in psychedelic medicine and neuroplasticity, including Gilgamesh in the portfolio and a reported SPV participation in Beckley Psytech, which makes it a meaningful investor stakeholder for the psychedelic ecosystem even though its broader strategy is much wider than psychedelics alone.

Investor Type

Venture Capital Fund

Geographic Scope

Global

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement

Active

Investment Stage Focus

SeedSeries A/BGrowth / Late Stage

Investment Focus Areas

Drug Development

Investment Orientation

Engagement Status

Active

Investor Type

Venture Capital Fund

Investment Website

Portfolio Stakeholders

Recorded Investments

Gilgamesh Pharma

Date unknown

private placement

Listed by Prime Movers Lab as a portfolio company with a psychedelic medicine focus.

Prime Movers Lab | Portfolio
Beckley Psytech

Date unknown

series round via SPV - undisclosed

Prime Movers Lab said it participated in Beckley Psytech’s most recent round through an SPV.

Psychedelic Medicine

The Path

Date unknown

seed - $14 million

Prime Movers Lab led the seed round for The Path, an AI therapy startup with adjacency to mental health and psychedelic-style care models.

Prime Movers Lab | News

Quick Facts

Founded
2016
HQ
Jackson / Teton Village, Wyoming, United States
Website
Visit